Epithelial-Mesenchymal Transition and Podocyte Loss in Diabetic Kidney Disease

American Journal of Kidney Diseases

Volumn 54, Issue 4, 2009, Pages 590-593

  Reidy, Kimberly ^a   Susztak, Katalin ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; NEPHRIN; P CADHERIN; PROTEIN ZO1; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA;

CELL CULTURE; CELL LOSS; CELL STRUCTURE; CELL VIABILITY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; EPITHELIUM CELL; GLOMERULUS FILTRATION RATE; HUMAN; MESENCHYME; NONHUMAN; PHENOTYPE; PODOCYTE; PROTEIN EXPRESSION; PROTEINURIA;

BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; EPITHELIAL CELLS; HUMANS; MESODERM; PODOCYTES; PROTEINURIA; TRANSFORMING GROWTH FACTOR BETA;

EID: 70349251778     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.07.003     Document Type: Editorial

References (29)

1. Huber T.B., Hartleben B., Winkelmann K., et al. Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic syndrome. J Am Soc Nephrol 20 (2009) 798-806
2. Reiser J., Kriz W., Kretzler M., and Mundel P. The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol 11 (2000) 1-8
3. Pavenstadt H., Kriz W., and Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 83 (2003) 253-307
4. Pagtalunan M.E., Miller P.L., Jumping-Eagle S., et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99 (1997) 342-348
5. Kim Y.H., Goyal M., Kurnit D., et al. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Intl 60 (2001) 957-968
6. Petermann A.T., Pippin J., Krofft R., et al. Viable podocytes detach in experimental diabetic nephropathy: Potential mechanism underlying glomerulosclerosis. Nephron 98 (2004) e114-e123
7. Li J.H., Huang X.R., Zhu H.J., et al. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: Implications for diabetic renal and vascular disease. FASEB J 18 (2004) 176-178
8. Szabo C., Biser A., Benko R., Bottinger E., and Susztak K. Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice. Diabetes 55 (2006) 3004-3012
9. Niranjan T., Bielesz B., Gruenwald A., et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 14 (2008) 290-298
10. Wolf G., Chen S., and Ziyadeh F.N. From the periphery of the glomerular capillary wall toward the center of disease: Podocyte injury comes of age in diabetic nephropathy. Diabetes 54 (2005) 1626-1634
11. Schiffer M., Bitzer M., Roberts I.S., et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108 (2001) 807-816
12. Doublier S., Salvidio G., Lupia E., et al. Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52 (2003) 1023-1030
13. Susztak K., Ciccone E., McCue P., Sharma K., and Bottinger E.P. Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med 2 (2005) e45
14. Vogelmann S.U., Nelson W.J., Myers B.D., and Lemley K.V. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol 285 (2003) F40-F48
15. Pozzi A., Jarad G., Moeckel G.W., et al. Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity. Dev Biol 316 (2008) 288-301
16. Durvasula R.V., and Shankland S.J. Podocyte injury and targeting therapy: An update. Curr Opin Nephrol Hypertens 15 (2006) 1-7
17. Skoberne A., Konieczny A., and Schiffer M. Glomerular epithelial cells in the urine: What has to be done to make them worthwhile?. Am J Physiol 296 (2009) F230-F241
18. Shankland S.J. The podocyte's response to injury: Role in proteinuria and glomerulosclerosis. Kidney Int 69 (2006) 2131-2147
19. Yamaguchi Y., Iwano M., Suzuki D., et al. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis 54 (2009) 653-664
20. Ziyadeh F.N. Mediators of diabetic renal disease: The case for TGF-beta as the major mediator. J Am Soc Nephrol 15 suppl 1 (2004) S55-S57
21. Bitzer M., Sterzel R.B., and Bottinger E.P. Transforming growth factor-beta in renal disease. Kidney Blood Press Res 21 (1998) 1-12
22. Li Y., Kang Y.S., Dai C., Kiss L.P., Wen X., and Liu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 172 (2008) 299-308
23. Li Y., Yang J., Dai C., Wu C., and Liu Y. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112 (2003) 503-516
24. Thiery J.P., and Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7 (2006) 131-142
25. Yang J., and Weinberg R.A. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell 14 (2008) 818-829
26. Shankland S.J., Pippin J.W., Reiser J., and Mundel P. Podocytes in culture: Past, present, and future. Kidney Int 72 (2007) 26-36
27. El-Aouni C., Herbach N., Blattner S.M., et al. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis. J Am Soc Nephrol 17 (2006) 1334-1344
28. Dai C., Stolz D.B., Bastacky S.I., et al. Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol 17 (2006) 2164-2175
29. Hirose T., Satoh D., Kurihara H., et al. An essential role of the universal polarity protein, aPKClambda, on the maintenance of podocyte slit diaphragms. PLoS ONE 4 (2009) e4194